The set of Endoret® technology (prgf®) formulations represent a solution in terms of safety, efficacy and reproducibility that ophthalmologists demanded in the treatment of various ocular pathologies.
The fibrin-free growth factor-rich plasma formulation has been developed for daily use, is stored at room temperature, and can be used anywhere, anytime.
Autologous fibrin formulations of plasma rich in growth factors act as a scaffold in eye surgeries, accelerating recovery, improving visual acuity and decreasing pain and inflammation and reducing fibrosis.
Autologous eye drops are used in pathologies such as:
Using the different autologous fibrin formulations improves eye surgery treatments such as: